Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning
Nelson, Michelle H., Bowers, Jacob S., Bailey, Stefanie R., Diven, Marshall A., Fugle, Caroline W., Kaiser, Andrew D. M., Wrzesinski, Claudia, Liu, Bei, Restifo, Nicholas P., Paulos, Chrystal M.Volume:
4
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-016-0110-8
Date:
December, 2016
File:
PDF, 1.84 MB
english, 2016